Keystone Financial Planning, Inc. Abb Vie Inc. Transaction History

Keystone Financial Planning, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $694,478 - $861,652	-5,262 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $9,150 - $10,387	86 Added 1.66%	5,262 $568,000
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $10,521 - $11,721	100 Added 1.97%	5,176 $583,000
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $354,558 - $452,880	5,076	5,076 $451,000

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Keystone Financial Planning, Inc., based on Form 13F filings with the SEC.

Stay updated on Keystone Financial Planning, Inc. with notifications on news.